170 related articles for article (PubMed ID: 33005003)
1. 3-Year results following treatment with the second generation of the temporary implantable nitinol device in men with LUTS secondary to benign prostatic obstruction.
Amparore D; Fiori C; Valerio M; Schulman C; Giannakis I; De Cillis S; Kadner G; Porpiglia F
Prostate Cancer Prostatic Dis; 2021 Jun; 24(2):349-357. PubMed ID: 33005003
[TBL] [Abstract][Full Text] [Related]
2. Second generation of temporary implantable nitinol device (iTind) in men with LUTS: 2 year results of the MT-02-study.
Kadner G; Valerio M; Giannakis I; Manit A; Lumen N; Ho BSH; Alonso S; Schulman C; Barber N; Amparore D; Porpiglia F
World J Urol; 2020 Dec; 38(12):3235-3244. PubMed ID: 32124019
[TBL] [Abstract][Full Text] [Related]
3. Second-generation of temporary implantable nitinol device for the relief of lower urinary tract symptoms due to benign prostatic hyperplasia: results of a prospective, multicentre study at 1 year of follow-up.
Porpiglia F; Fiori C; Amparore D; Kadner G; Manit A; Valerio M; Nicolaas L; Ho BSH; Alonso S; Schulman C; Barber N
BJU Int; 2019 Jun; 123(6):1061-1069. PubMed ID: 30382600
[TBL] [Abstract][Full Text] [Related]
4. Urinary and sexual function after treatment with temporary implantable nitinol device (iTind) in men with LUTS: 6-month interim results of the MT-06-study.
De Nunzio C; Cantiello F; Fiori C; Crocerossa F; Tognoni P; Amparore D; Baldassarri V; Elbers JR; Sancha FG; Porpiglia F
World J Urol; 2021 Jun; 39(6):2037-2042. PubMed ID: 32851439
[TBL] [Abstract][Full Text] [Related]
5. Temporary implantable nitinol device (TIND): a novel, minimally invasive treatment for relief of lower urinary tract symptoms (LUTS) related to benign prostatic hyperplasia (BPH): feasibility, safety and functional results at 1 year of follow-up.
Porpiglia F; Fiori C; Bertolo R; Garrou D; Cattaneo G; Amparore D
BJU Int; 2015 Aug; 116(2):278-87. PubMed ID: 25382816
[TBL] [Abstract][Full Text] [Related]
6. 3-Year follow-up of temporary implantable nitinol device implantation for the treatment of benign prostatic obstruction.
Porpiglia F; Fiori C; Bertolo R; Giordano A; Checcucci E; Garrou D; Cattaneo G; De Luca S; Amparore D
BJU Int; 2018 Jul; 122(1):106-112. PubMed ID: 29359881
[TBL] [Abstract][Full Text] [Related]
7. The iTind Temporarily Implanted Nitinol Device for the Treatment of Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia: A Multicenter, Randomized, Controlled Trial.
Chughtai B; Elterman D; Shore N; Gittleman M; Motola J; Pike S; Hermann C; Terrens W; Kohan A; Gonzalez RR; Katz A; Schiff J; Goldfischer E; Grunberger I; Tu LM; Alshak MN; Kaminetzky J
Urology; 2021 Jul; 153():270-276. PubMed ID: 33373708
[TBL] [Abstract][Full Text] [Related]
8. Temporary implantable nitinol device for benign prostatic hyperplasia-related lower urinary tract symptoms: over 48-month results.
Amparore D; De Cillis S; Schulman C; Kadner G; Fiori C; Porpiglia F
Minerva Urol Nephrol; 2023 Dec; 75(6):743-751. PubMed ID: 37350585
[TBL] [Abstract][Full Text] [Related]
9. First-in-man Safety and Efficacy of the ClearRing Implant for the Treatment of Benign Prostatic Hyperplasia.
Vjaters E; Nitsan D; Mullerad M; Engelstein D; Leibovitch I; Feld Y
Eur Urol Focus; 2020 Jan; 6(1):131-136. PubMed ID: 30293945
[TBL] [Abstract][Full Text] [Related]
10. The EXPANDER-1 trial: introduction of the novel Urocross™ Expander System for treatment of lower urinary tract symptoms (LUTS) secondary to benign prostatic hyperplasia (BPH).
Woo HH; Huang CP; Huang WJ; Chang YH; Lien CS; Chkhotua A; Elterman DS
Prostate Cancer Prostatic Dis; 2022 Sep; 25(3):576-582. PubMed ID: 35641601
[TBL] [Abstract][Full Text] [Related]
11. First- and Second-Generation Temporary Implantable Nitinol Devices As Minimally Invasive Treatments for BPH-Related LUTS: Systematic Review of the Literature.
Amparore D; De Cillis S; Volpi G; Checcucci E; Manfredi M; Morra I; Di Dio M; Fiori C; Porpiglia F;
Curr Urol Rep; 2019 Jul; 20(8):47. PubMed ID: 31278441
[TBL] [Abstract][Full Text] [Related]
12. Modified holmium laser enucleation for benign prostatic obstruction to preserve sexual and ejaculatory function.
Long Depaquit T; Baboudjian M; Chiron P; Corral R; Anastay V; Bastide C; Toledano H
Fr J Urol; 2024 Mar; 34(2):102581. PubMed ID: 38717462
[TBL] [Abstract][Full Text] [Related]
13. The prostatic urethral lift for the treatment of lower urinary tract symptoms associated with prostate enlargement due to benign prostatic hyperplasia: the L.I.F.T. Study.
Roehrborn CG; Gange SN; Shore ND; Giddens JL; Bolton DM; Cowan BE; Brown BT; McVary KT; Te AE; Gholami SS; Rashid P; Moseley WG; Chin PT; Dowling WT; Freedman SJ; Incze PF; Coffield KS; Borges FD; Rukstalis DB
J Urol; 2013 Dec; 190(6):2161-7. PubMed ID: 23764081
[TBL] [Abstract][Full Text] [Related]
14. Prostate Artery Embolization for Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia: Results From a Prospective FDA-Approved Investigational Device Exemption Study.
Salem R; Hairston J; Hohlastos E; Riaz A; Kallini J; Gabr A; Ali R; Jenkins K; Karp J; Desai K; Thornburg B; Casalino D; Miller F; Hofer M; Hamoui N; Mouli S
Urology; 2018 Oct; 120():205-210. PubMed ID: 30036614
[TBL] [Abstract][Full Text] [Related]
15. Minimally invasive prostatic urethral lift (PUL) efficacious in TURP candidates: a multicenter German evaluation after 2 years.
Sievert KD; Schonthaler M; Berges R; Toomey P; Drager D; Herlemann A; Miller F; Wetterauer U; Volkmer B; Gratzke C; Amend B
World J Urol; 2019 Jul; 37(7):1353-1360. PubMed ID: 30283994
[TBL] [Abstract][Full Text] [Related]
16. Prostatic Urethral Lift: A New Minimally Invasive Treatment for Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia.
Bozkurt A; Karabakan M; Keskin E; Hirik E; Balci MB; Nuhoglu B
Urol Int; 2016; 96(2):202-6. PubMed ID: 26613256
[TBL] [Abstract][Full Text] [Related]
17. An Evaluation of Sexual Function in the Treatment of Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia in Men Treated with the Temporarily Implanted Nitinol Device.
Elterman D; Alshak MN; Martinez Diaz S; Shore N; Gittleman M; Motola J; Pike S; Hermann C; Terens W; Kohan A; Gonzalez R; Katz A; Schiff J; Goldfischer E; Grunberger I; Tu L; Kaminetsky J; Chughtai B
J Endourol; 2023 Jan; 37(1):74-79. PubMed ID: 36070450
[No Abstract] [Full Text] [Related]
18. What's New in TIND?
Marcon J; Magistro G; Stief CG; Grimm T
Eur Urol Focus; 2018 Jan; 4(1):40-42. PubMed ID: 29705283
[TBL] [Abstract][Full Text] [Related]
19. Treatment of LUTS secondary to BPH while preserving sexual function: randomized controlled study of prostatic urethral lift.
McVary KT; Gange SN; Shore ND; Bolton DM; Cowan BE; Brown BT; Te AE; Chin PT; Rukstalis DB; Roehrborn CG;
J Sex Med; 2014 Jan; 11(1):279-87. PubMed ID: 24119101
[TBL] [Abstract][Full Text] [Related]
20. Temporarily implanted nitinol device versus prostatic urethral lift for minimally invasive surgical treatment of benign prostatic hyperplasia with lower urinary tract symptoms: a matching-adjusted indirect comparison.
Kernen KM; Omar S; Goodnight B; Skodny P; Bruce S; Yu TM
Can J Urol; 2023 Oct; 30(5):11676-11685. PubMed ID: 37838995
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
